Timothy A Hagen

Title: Innovator Spotlight: Timothy A. Hagen

Introduction: Timothy A. Hagen is a notable inventor based in East Lyme, Connecticut, recognized for his contribution to pharmaceutical innovations. His work focuses on enhancing the effectiveness of azithromycin while minimizing side effects, an important advancement in the field of medicine.

Latest Patents: Timothy holds a patent for "Azithromycin dosage forms with reduced side effects." This invention involves a novel oral dosage form that includes an effective amount of an alkalizing agent and azithromycin multiparticulate. The multiparticulate is composed of azithromycin combined with specific glycerides, such as glyceryl monobehenate, glyceryl dibehenate, glyceryl tribehenate, or their mixtures, along with a poloxamer. The patent outlines various suitable oral dosing options, including powders for oral suspension, unit dose packets, tablets, or capsules.

Career Highlights: Timothy A. Hagen is associated with Pfizer Corporation, a prominent player in the pharmaceutical industry. His position there has allowed him to contribute to significant advancements in medication delivery systems and formulations, impacting patient care and treatment outcomes.

Collaborations: Throughout his career, Timothy has collaborated with esteemed colleagues, including Julian B. Lo and Avinash G. Thombre. These collaborations highlight the importance of teamwork and collective expertise in driving innovation within the pharmaceutical field.

Conclusion: Timothy A. Hagen's innovative approach to azithromycin dosage forms exemplifies the role of inventors in advancing healthcare. His dedication to developing formulations that reduce side effects lays the groundwork for improved medicinal efficacy, ultimately benefiting patients and the medical community alike.